与「ProstateCancer」相关的搜索结果

This less invasive therapy for prostate cancer is just as effective as surgery or radiotherapy but with a lower risk of side effects, a major study suggests. #Cancer# #ProstateCancer# #Health# #Treatment#

ARTO long-term analysis Adding SBRT to abiraterone acetate + prednisone + ADT may improve outcomes in selected patients with oligometastatic CRPC. At 53-month median follow-up • OS: not reached vs 50 mo • HR 0.55; p=0.021 • bPFS: 44 vs 18 mo • rPFS: 44 vs 17 mo • 4-yr PC-specific survival: 86.6% vs 67.7% No new safety concerns were reported. @MicheleAquilano @alessiobruni @BarbaraJereczek @GabSimontacchi @PierluigiBonomo @ChadTangMD #ProstateCancer# #GUOncology# #SBRT# #Oncology#

Rectal spacers in prostate radiotherapy: Balancing efficacy, safety, and patient experience. Michael Greenberg, MD @JeffersonUniv & @DanWelchons @AMPofNY join @zklaassen_md @GACancerCenter to discuss rectal spacing before #ProstateCancer# radiotherapy. They trace the product evolution from SpaceOAR's pegylated hydrogel to Barrigel®. #WatchNow# on UroToday > @Barrigel_spacer @teleflex

PSMA PET/CT–Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study In this prospective single-center study of 63 men with negative or equivocal mpMRI (PI-RADS 2–3), PSMA PET/CT–guided targeted biopsy 💉 significantly outperformed systematic biopsy for detecting clinically significant #ProstateCancer# (37% vs. 21%). Combining both approaches further improved detection. SUVmax independently predicted clinically significant disease, while dynamic total-body PET kinetic parameters enhanced lesion characterization, particularly in equivocal cases. These findings support PSMA PET/CT as a valuable adjunct for biopsy guidance and risk stratification. @andrea_farolfi @stefanofanti4 @riccardoschiav6 @drMDrog @OncoAlert 🚨 #LPCCC27# @Silke_Gillessen @AOmlin @ProfKHerrmann Jochen Walz @weoncologists

CHHiP vs PROFIT for Localized Prostate Cancer: A Retrospective Dosimetric Comparison of Organs at Risk 🔗 Find the full research article: Moderate hypofractionation for localized prostate cancer has become a standard of care in many radiation therapy centers worldwide. Several fractionation and planning protocols exist, with CHHiP and PROFIT (60 Gy in 20 fractions) being 2 of the most commonly used. We retrospectively compared the doses received by organs at risk (OARs) using these 2 protocols. #ProstateCancer# #RadiationOncology# #RadOnc# #MensHealthMonth# #MHM26# #CaseStudy# #RadOncEd# #MedEd#

Genomic classifiers and AI for personalizing #ProstateCancer# radiation therapy. @drjefstathiou @MassGenBrigham joins @neerajaiims @huntsmancancer to discuss the use of genomic classifiers and AI-based tools in personalizing radiation therapy for prostate cancer. #WatchNow# on UroToday > #APCCC26# @Decipher_VCYT @APCCC_Lugano @arteraAI

A man approached me after our event in Strongsville to convey that he was benefiting from the drug my company developed for prostate cancer. So grateful. Let’s pray for his health & continued recovery. 🙏

Introducing #APCCC26# Live from Lugano🇨🇭Brought to you from APCCC together with @OncoAlert 🚨 Triplet vs Doublet Therapy in Metastatic Hormone-Sensitive Prostate Cancer | APCCC 2026 Expert Discussion Join Dr. Jones, Dr. Rathkopf, and Dr. Fizazi for an expert discussion on one of the most rapidly evolving questions in genitourinary oncology: the optimal treatment approach for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Series Faculty @BertrandTOMBAL @ChrisSweens1 @jmmrad @drjefstathiou @CaPsurvivorship @LoebStacy @charlesryanmd @AarmstrongDuke @Ecastromarcos @LVM_Walz @piet_ost @Nicola_Fossati @AnthonyMJoshua @Prof_Nick_James @VedangMurthy @AttardLab @Silke_Gillessen @AOmlin Pinging @AmandaNizamMD @scocmem @nataliagandur @gu_onc @tompowles1 @brian_rini @declangmurphy @cdanicas @neerajaiims

How can multidisciplinary involvement improve patient-centered care in hormone-sensitive prostate cancer (HSPC)? Watch Axel Merseburger discuss the importance of communication and knowledge exchange in HSPC management – free and on demand